Key Takeaways
- PLTR shares declined approximately 6% following Michael Burry’s warning about a potential market bubble
- Burry asserts Anthropic is capturing Palantir’s enterprise customers, pointing to ARR expansion from $9B to $30B
- The company’s forward P/E ratio stands at roughly 115x, significantly exceeding the sector median of 21x
- Wall Street remains divided: Rosenblatt maintains a $200 Buy rating while Benchmark expresses valuation worries
- The Street consensus leans toward Moderate Buy with a mean price target of $194.61
The renowned investor from “The Big Short,” Michael Burry, unleashed fresh criticism of Palantir through a social media post on Wednesday, warning that the stock represents a potential bubble while highlighting Anthropic’s growing dominance in the enterprise AI sector.
The remarks triggered a roughly 6% decline in PLTR during Wednesday’s trading session. However, shares recovered slightly to approximately $141.18 in extended trading as some investors viewed the dip as a buying opportunity.
Palantir Technologies Inc., PLTR
Burry previously revealed a short bet against Palantir earlier in the year. His recent commentary escalates his critique by suggesting fundamental changes in the competitive environment.
“Anthropic is eating Palantir’s lunch,” Burry declared. “That massive boost from $9B to $30B ARR at Anthropic is because Anthropic offers the easier, cheaper, intuitive solution for businesses.”
He supported his argument with information from corporate spending platform Ramp, referencing a March 2026 study conducted by economist Ara Kharazian. The research revealed that approximately 25% of Ramp customers now subscribe to Anthropic services — a dramatic increase from just 4% twelve months earlier.
Burry further highlighted that 73% of fresh enterprise AI investments are flowing to Anthropic, while noting the market exhibits zero-sum characteristics, with OpenAI experiencing its steepest monthly user decline ever recorded.
Premium Valuation Under Scrutiny
Trading at a forward price-to-earnings multiple near 115x, Palantir commands a substantial premium over its sector median of 21x and dwarfs comparable large-cap AI competitors. This valuation disparity has consistently fueled bearish sentiment.
Benchmark analyst Yi Fu Lee maintains a cautious stance with a Hold rating. His concern centers on the stock pricing in flawless operational performance, leaving limited margin for any growth deceleration.
Rosenblatt analyst John McPeake offers a contrasting perspective. He reaffirmed his Buy recommendation with a $200 target, highlighting forthcoming positive developments including the “Golden Dome” missile defense initiative. McPeake projects Palantir’s involvement in this contract could deliver multi-billion dollar revenues extending through 2028.
Bank of America analyst Mariana Perez similarly holds a Buy rating, characterizing the selloff as a temporary response to negative headlines. She emphasizes Palantir’s entrenched position in sensitive government data infrastructure as a sustainable competitive moat.
Analyst Community Perspective
The current Wall Street consensus stands at Moderate Buy, reflecting 14 Buy recommendations, 5 Hold ratings, and 2 Sell calls.
The mean analyst price target following Wednesday’s turbulence remains positioned at $194.61, suggesting approximately 38% potential appreciation from the session’s closing price.
Palantir delivered 70% year-over-year revenue expansion in its latest quarterly report, a metric that bullish analysts cite as confirmation that underlying business momentum continues despite valuation controversies.
Burry isn’t the only prominent skeptic. Short-seller Andrew Left revealed a bearish position in Palantir last September, simultaneously identifying Databricks as a superior investment alternative.
Since Anthropic remains privately held, investors cannot directly capitalize on Burry’s competitive thesis — though downward pressure on PLTR shares has been tangible.
The Maven Smart System receiving official authorization represents among the most concrete near-term positive catalysts for the stock.





